Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 2, Pages e1382791
Publisher
Informa UK Limited
Online
2017-09-29
DOI
10.1080/2162402x.2017.1382791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two-step enhanced cancer immunotherapy with engineeredSalmonella typhimuriumsecreting heterologous flagellin
- (2017) Jin Hai Zheng et al. Science Translational Medicine
- Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection
- (2017) Dino Kocijancic et al. Oncotarget
- Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility
- (2017) Dino Kocijancic et al. Oncotarget
- Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model
- (2016) Mako Yamamoto et al. PLoS One
- Biomimetic Salmonella: A Next-Generation Therapeutic Vector?
- (2016) Sebastian Felgner et al. TRENDS IN MICROBIOLOGY
- aroA -Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant
- (2016) Sebastian Felgner et al. mBio
- A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours
- (2016) Regino Mercado-Lubo et al. Nature Communications
- Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model
- (2016) Takashi Murakami et al. Oncotarget
- Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug
- (2016) Takashi Murakami et al. Oncotarget
- Therapy of solid tumors using probiotic Symbioflor-2 – restraints and potential
- (2016) Dino Kocijancic et al. Oncotarget
- Induction of CD4+and CD8+anti-tumor effector T cell responses by bacteria mediated tumor therapy
- (2015) Christian Stern et al. INTERNATIONAL JOURNAL OF CANCER
- Type IIFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
- (2015) Lisa Andzinski et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of inflammasome by attenuatedSalmonella typhimuriumin bacteria-mediated cancer therapy
- (2015) Thuy Xuan Phan et al. MICROBIOLOGY AND IMMUNOLOGY
- Quorum-sensingSalmonellaselectively trigger protein expression within tumors
- (2015) Charles A. Swofford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficiency of Conditionally Attenuated Salmonella enterica Serovar Typhimurium in Bacterium-Mediated Tumor Therapy
- (2015) Michael Frahm et al. mBio
- Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice
- (2015) Yong Zhang et al. Oncotarget
- Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
- (2015) Jung-Eun Kim et al. Theranostics
- Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models
- (2015) Yukihiko Hiroshima et al. PLoS One
- Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice
- (2015) Yukihiko Hiroshima et al. PLoS One
- Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models
- (2015) Yukihiko Hiroshima et al. Oncotarget
- Identification ofStaphylococcus aureusα-hemolysin as a protein drug that is secreted by anticancer bacteria and rapidly kills cancer cells
- (2014) Charles A. Swofford et al. BIOTECHNOLOGY AND BIOENGINEERING
- Effective Cancer Vaccine Platform Based on Attenuated Salmonella and a Type III Secretion System
- (2014) X. Xu et al. CANCER RESEARCH
- Efficacy ofSalmonella typhimuriumA1-R Versus Chemotherapy on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX)
- (2014) Yukihiko Hiroshima et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-Tumoral Effect of the Mitochondrial Target Domain of Noxa Delivered by an Engineered Salmonella typhimurium
- (2014) Jae-Ho Jeong et al. PLoS One
- Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
- (2014) N. J. Roberts et al. Science Translational Medicine
- The role of flagella and chemotaxis genes in host pathogen interaction of the host adapted Salmonella enterica serovar Dublin compared to the broad host range serovar S. Typhimurium
- (2013) John Elmerdahl Olsen et al. BMC MICROBIOLOGY
- Salmonella T3SSs: successful mission of the secret(ion) agents
- (2013) Thomas P Moest et al. CURRENT OPINION IN MICROBIOLOGY
- Enhancement of Host Immune Responses by Oral Vaccination to Salmonella enterica serovar Typhimurium Harboring Both FliC and FljB Flagella
- (2013) Jeong Seon Eom et al. PLoS One
- Modulating the innate immune response by combinatorial engineering of endotoxin
- (2013) Brittany D. Needham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
- (2013) Laura Green et al. Cancers
- YdiV: a dual function protein that targets FlhDC for ClpXP-dependent degradation by promoting release of DNA-bound FlhDC complex
- (2012) Akiko Takaya et al. MOLECULAR MICROBIOLOGY
- Evaluation ofClostridium novyi–NT spores in dogs with naturally occurring tumors
- (2011) Erika L. Krick et al. AMERICAN JOURNAL OF VETERINARY RESEARCH
- The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages
- (2011) Robert M Hoffman Expert Opinion on Drug Discovery
- Influence of infection route and virulence factors on colonization of solid tumors bySalmonella entericaserovar Typhimurium
- (2011) Katja Crull et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Bacterial Nanomachines: The Flagellum and Type III Injectisome
- (2010) M. Erhardt et al. Cold Spring Harbor Perspectives in Biology
- Genetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer
- (2009) V. H. Nguyen et al. CANCER RESEARCH
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Tumor Invasion of Salmonella enterica Serovar Typhimurium Is Accompanied by Strong Hemorrhage Promoted by TNF-α
- (2009) Sara Leschner et al. PLoS One
- Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo
- (2009) P Enck et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Containment of Tumor-Colonizing Bacteria by Host Neutrophils
- (2008) K. Westphal et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now